Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Global Healthcare Ishares ETF (IXJ)

Global Healthcare Ishares ETF (IXJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 3,800,100,400
  • Shares Outstanding, K 44,850
  • 60-Month Beta 0.67
  • Price/Earnings ttm 21.81
  • Annual Dividend & Yield 1.29 (1.52%)
  • Most Recent Dividend 0.617 on 12/17/24
  • Management Fee 0.40%
  • INDUSTRY GROUPING:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 21.50% ( -0.27%)
  • Historical Volatility 22.32%
  • IV Percentile 86%
  • IV Rank 60.26%
  • IV High 33.86% on 04/08/25
  • IV Low 2.76% on 07/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 10
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 75
  • Open Int (30-Day) 80

Price Performance

See More
Period Period Low Period High Performance
1-Month
81.85 +2.93%
on 05/15/25
89.35 -5.71%
on 04/30/25
-1.64 (-1.91%)
since 04/23/25
3-Month
80.68 +4.42%
on 04/09/25
94.32 -10.67%
on 03/05/25
-7.50 (-8.17%)
since 02/21/25
52-Week
80.68 +4.42%
on 04/09/25
101.31 -16.84%
on 08/30/24
-8.16 (-8.83%)
since 05/23/24

Most Recent Stories

More News
Recession Fears Looming? Secure Your Portfolio With These ETFs

President Trump's reciprocal tariffs have weakened U.S. consumer and business sentiment, as consumers grow uncertain about the 'chaotic' U.S. policy, according to Reuters.Global growth concerns have resurfaced...

XLU : 81.06 (+1.20%)
SPHQ : 68.99 (-0.72%)
RSPS : 30.06 (+0.13%)
XLV : 130.34 (-0.16%)
VHT : 239.13 (-0.19%)
QUAL : 174.01 (-1.03%)
QUS : 156.85 (-0.49%)
JQUA : 58.03 (-0.50%)
VDC : 220.46 (+0.26%)
FUTY : 52.23 (+1.20%)
IYH : 54.49 (-0.22%)
VPU : 175.10 (+1.18%)
Cigna Group Stock: Is CI Outperforming the Healthcare Sector?

Due to Cigna Group’s outperformance relative to its healthcare sector on a YTD basis, Wall Street analysts maintain bullish about the stock’s prospects.

CI : 315.99 (+1.06%)
IXJ : 84.25 (-0.01%)
ELV : 372.27 (-3.18%)
Are Wall Street Analysts Bullish on Danaher Stock?

Healthcare giant Danaher has significantly underperformed the broader market over the past year, yet analysts remain strongly bullish on the stock’s longer-term prospects.

C : 73.09 (-0.45%)
$SPX : 5,802.82 (-0.67%)
IXJ : 84.25 (-0.01%)
DHR : 184.54 (-1.57%)
DHR : 184.54 (-1.57%)
Is Your Portfolio Ready for a Trade War? ETFs for a Defensive Play

Staying true to his campaign promises, President Donald Trump imposed tariffs on the United States’ largest trade partners — Mexico, Canada and China — resulting in the market reacting negatively....

XLU : 81.06 (+1.20%)
SPHQ : 68.99 (-0.72%)
GOOG : 169.59 (-1.39%)
XLV : 130.34 (-0.16%)
VHT : 239.13 (-0.19%)
ILMN : 80.37 (-0.21%)
IVV : 582.00 (-0.64%)
QUAL : 174.01 (-1.03%)
GLDM : 66.57 (+2.18%)
JQUA : 58.03 (-0.50%)
VDC : 220.46 (+0.26%)
FUTY : 52.23 (+1.20%)
AbbVie Stock Nears 3-Month High on Q4 Beat As Immunology Growth Eases Humira Slump: Retail Mood Brightens

The company raised its long-term sales outlook for Skyrizi and Rinvoq, now expecting combined revenue of about $24 billion in 2025.

XLV : 130.34 (-0.16%)
IXJ : 84.25 (-0.01%)
ABBV : 183.26 (+0.39%)
FDL : 41.41 (+0.41%)
J&J Stock Dips As 2025 Sales Guidance Misses Estimate, But Retail Mood Resilient

During the earnings call, J&J highlighted several growth drivers, including its positioning for 5%-7% annual growth through 2030 and plans to increase its dividend annually.

XLV : 130.34 (-0.16%)
JNJ : 152.94 (+0.22%)
IXJ : 84.25 (-0.01%)
DIA : 416.33 (-0.59%)
2025 Market Uncertainty? ETFs to Steady Your Portfolio

Escalating geopolitical tensions and the stalling of the decline in U.S. inflation highlight defensive funds as a smart investment choice. According to Liz Ann Sonders, chief investment strategist at Charles...

XLU : 81.06 (+1.20%)
SPHQ : 68.99 (-0.72%)
XLV : 130.34 (-0.16%)
VHT : 239.13 (-0.19%)
QUAL : 174.01 (-1.03%)
GLDM : 66.57 (+2.18%)
JQUA : 58.03 (-0.50%)
VDC : 220.46 (+0.26%)
FUTY : 52.23 (+1.20%)
VPU : 175.10 (+1.18%)
IYK : 70.68 (+0.64%)
IXJ : 84.25 (-0.01%)
AbbVie Stock Volatile On $200M Deal To Buy Nimble Therapeutics: Retail Still Bearish

This cautious stance follows a series of setbacks for AbbVie, including last month’s failure of two mid-stage trials for a schizophrenia drug.

IXJ : 84.25 (-0.01%)
VTI : 285.04 (-0.59%)
ABBV : 183.26 (+0.39%)
Want to Earn More in the Stock Market With Less Effort? Try This Simple Strategy

You don't need to be a stock market expert to earn above-average returns.

VGT : 595.09 (-1.18%)
VOO : 532.40 (-0.68%)
IBB : 121.25 (-0.14%)
IYH : 54.49 (-0.22%)
IXJ : 84.25 (-0.01%)
IHI : 60.71 (-0.28%)
Top ETFs for Every Sector

Top ETFs for all 11 S&P 500 sectors.

XLU : 81.06 (+1.20%)
VGT : 595.09 (-1.18%)
XLV : 130.34 (-0.16%)
XLY : 210.65 (-0.90%)
FDIS : 90.98 (-0.77%)
XLC : 100.19 (-0.46%)
XLB : 85.70 (-0.20%)
XLE : 81.99 (+0.32%)
XLF : 50.05 (-0.36%)
XLI : 140.83 (-0.33%)
XLK : 226.81 (-1.10%)
VNQ : 87.09 (+0.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The iShares Global Healthcare ETF seeks to track the investment results of an index composed of global equities in the healthcare sector. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the SP Global Healthcare Sector Index...

See More

Top 10 Holdings

Key Turning Points

3rd Resistance Point 85.13
2nd Resistance Point 84.75
1st Resistance Point 84.50
Last Price 84.25
1st Support Level 83.87
2nd Support Level 83.49
3rd Support Level 83.24

See More

52-Week High 101.31
Fibonacci 61.8% 93.43
Fibonacci 50% 90.99
Fibonacci 38.2% 88.56
Last Price 84.25
52-Week Low 80.68

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar